| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.23B | $972.0M | $729.7M |
| YoY Revenue Growth % | +26.7% | +33.2% | — |
| Gross Profit | $1.10B | $868.3M | — |
| Gross Margin % | 89.2% | 89.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$1.7M | -$21.0M | -$38.6M |
| Operating Margin % | -0.1% | -2.2% | -5.3% |
| Net Income (GAAP) | $118.7M | $32.4M | -$1.9M |
| EBITDA (Normalized) | $14.5M | -$10.5M | -$12.3M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $333.6M | $311.1M | $215.4M |
| Capital Expenditures (CapEx) | $20.4M | $13.2M | $32.8M |
| Free Cash Flow (FCF) | $313.3M | $297.9M | $182.6M |
| FCF Margin % | 25.4% | 30.6% | 25.0% |
| Return on Invested Capital (ROIC %) | -1.1% | -45.0% | -2.3% |
| Cash & Short-Term Equivalents | $1.50B | $1.41B | — |
| Total Debt (Short + Long Term) | $386.9M | $294.9M | $523.4M |
| Total Stockholders' Equity | $1.25B | $1.03B | $1.07B |